3 terminated, 2 completed, 1 recruiting, 1 unknown. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Terminated 3, Completed 2, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Cranial Nerve Neoplasms: new trials by email Literature Review of Cranial Nerve Neoplasms trials Research Report on Cranial Nerve Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients Steroids therapy, Placebo - Vestibular Schwannoma, Facial Nerve Paralysis | Phase 3 | Recruiting | Beijing Tiantan Hospital | 364 | 2025-10-09 | 2026-10-26 |
| Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas REC-2282, Placebo - Neurofibromatosis Type 2 | Phase 2 / Phase 3 | Terminated | Recursion Pharmaceuticals Inc. | 25 | 2022-06-20 | 2026-08-17 |
| Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections Brolucizumab, Aflibercept - Age-Related Macular Degeneration | Phase 3 | Terminated | Novartis Pharmaceuticals | 535 | 2018-10-30 | 2023-01-30 |
| Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma Temozolomide, ANP Therapy - Optic Nerve Glioma | Phase 3 | Withdrawn | Burzynski Research Institute | 2011-12-01 | 2017-07-26 | |
| Stereotactic Radiation in Vestibular Schwannoma stereotactic radiotherapy, stereotactic radiosurgery - Vestibular Schwannoma | Phase 3 | Unknown | Ramathibodi Hospital | 200 | 2011-10-01 | 2011-10-10 |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer cyproheptadine hydrochloride, placebo - Cancer | Phase 3 | Terminated | University of South Florida | 22 | 2010-06-01 | 2015-07-02 |
| Corticosteroids in Prevention of Facial Palsy After Cranial Base Surgery methylprednisolone - Facial Palsy | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 313 | 2007-03-01 | 2012-07-10 |
| Combination Chemotherapy in Treating Children With Progressive Brain Tumors carboplatin, lomustine, procarbazine hydrochloride - Brain Tumors, Central Nervous System Tumors | Phase 3 | Completed | Children's Oncology Group | 428 | 1997-04-01 | 2013-09-09 |
Neuroma, Acoustic (3) · Optic Nerve Glioma (3) · Astrocytoma (2) · Facial Paralysis (2) · Neurofibromatosis 2 (2) · Bell Palsy (1) · Body Weight Changes (1) · Bone Neoplasms (1) · Brain Neoplasms (1) · Cachexia (1) · Central Nervous System Neoplasms (1) · Chondrosarcoma (1) · Choroid Plexus Neoplasms (1) · Familial ependymoma (1) · Fibrosarcoma (1)
Cranial Nerve Diseases (8) · Neoplasms by Histologic Type (8) · Neoplasms, Germ Cell and Embryonal (8) · Neoplasms, Nerve Tissue (8) · Nervous System Diseases (8) · Neuroectodermal Tumors (8) · Neoplasms (7) · Neoplasms by Site (6) · Nervous System Neoplasms (6) · Peripheral Nervous System Neoplasms (6) · Ear Diseases (5) · Nerve Sheath Neoplasms (5) · Neurilemmoma (5) · Neuroendocrine Tumors (5)
Carboplatin (1) · Cyproheptadine (1) · HDAC-42 (1) · Lomustine (1) · Methylprednisolone (1) · Procarbazine (1) · Radiosurgery (1) · Temozolomide (1) · Thioguanine (1) · Vincristine (1) · aflibercept (1) · antineoplaston A10 (1) · antineoplaston AS 2-1 (1) · brolucizumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Beijing Tiantan Hospital (1) · Burzynski Research Institute (1) · Children's Oncology Group (1) · Novartis Pharmaceuticals (1) · Ramathibodi Hospital (1) · Recursion Pharmaceuticals Inc. (1) · University of South Florida (1)
United States (4) · Australia (1) · Canada (1) · China (1) · France (1) · Netherlands (1) · New Zealand (1) · Puerto Rico (1) · Switzerland (1) · United Kingdom (1)
Jeffrey P. Krischer, PhD (1) · Joann Ater, MD (1) · Putipun Puataweepong, M.D. (1) · Stanislaw R Burzynski, MD, PhD (1)
U10CA081920 (1)